Alzheimer's Disease: Towards Early Detection: Recent Episodes
ReachMD
For health care professionals, time is truly of the essence to recognize, detect, and diagnose Alzheimer's disease earlier in clinical practice. Earlier diagnoses allow patients to access available treatments, build care teams and support networks, prepare advanced directives, and participate in clinical trials. ReachMD's dedicated series, Alzheimer's Disease: Towards Early Detection, explores innovative efforts by clinical experts across the country to research, practice, and teach new understandings of Alzheimer's diagnosis and care. From improved recognition strategies to advanced detection methods to clinical research updates and more, Alzheimer's Disease: Towards Early Detection provides clinicians with the key information needed to enhance patient care.
Guest: Marwan Noel Sabbagh, MD, FAAN, CCRI
Autophagy through sigma-1 receptor activation is a novel mechanism of action (MOA) in development for the treatment of Alzheimer’s disease. Join Dr. Marwan Noel Sabbagh as he breaks down this new MOA and recent clinical trial data.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Marc E. Agronin, MD
Guest: Anton Porsteinsson, MD
From expert specialists like internists and geriatric neuropsychiatrists to the patient themselves and their loved ones, there are a lot of individuals involved in an Alzheimer’s disease care team. So what are some best practices for collaborating and coordinating a patient’s care across all members of the team? Joining Dr. Charles Turck to share their perspectives are Dr. Marc Agronin from MIND Institute and Dr. Anton Porsteinsson from the University of Rochester.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Marc E. Agronin, MD
Over five million Americans currently suffer from Alzheimer’s disease, and that number is only expected to double in the next several decades. But what do we first need to understand about its pathophysiology so that we can better care for our patients with Alzheimer’s disease? To give us an in-depth look, Dr. Charles Turck is joined by Dr. Marc Agronin, Chief Medical Officer for MIND Institute and President of the American Association for Geriatric Psychiatry.
Guest: Kostas Lyketsos
The risk of Alzheimer’s disease increases substantially with age. In fact, about one in three adults aged 85 and older have dementia. So how do we screen for it, and what kind of impact can early detection have on our patients? Here to break down essential cognitive screening strategies for Alzheimer’s disease is Dr. Constantine Lyketsos, the Elizabeth Plank Althouse Professor for Alzheimer’s Research and Chair of Psychiatry at the Johns Hopkins Bayview Medical Center.
Guest: Peter Whitehouse, MD, PhD
Although obtaining specific statistics about the prevalence of Alzheimer’s disease can be difficult, what we do know is that its prevalence is increasing worldwide. With that in mind, Dr. Peter Whitehouse from Case Western Reserve University joins us to help uncover the unmet needs of patients, caregivers, and clinicians.
Guest: Peter Whitehouse, MD, PhD
What kind of impact can Alzheimer’s disease have on our patients, their caregivers, and the healthcare system as a whole? Here to help answer that key question is Dr. Peter Whitehouse, Professor of Neurology at Case Western Reserve University.
Host: Jennifer Caudle, DO
Guest: Douglas Scharre, MD, CMD
Cognitive assessment tools and detection tests for Alzheimer's disease are mutually designed to identify signs of cognitive impairment that are sometimes too subtle to catch by astute clinicians or even patients themselves. But what methods are available to help detect Alzheimer's as early as possible, and how do they impact quality of life for patients throughout the disease progression?
Host Dr. Jennifer Caudle welcomes Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry and Director of the Center for Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Carol Lippa, MD
Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients.
Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Carol Lippa, MD
Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Marwan Noel Sabbagh, MD, FAAN, CCRI
In efforts to detect and diagnose Alzheimer's Disease, time is of the essence. But there are numerous barriers that clinicians face in practice to establishing a diagnosis quickly and accurately, which affects quality of care for patients.
Joining host Dr. Matt Birnholz to address and consider solutions for these barriers is Dr. Marwan Sabbagh, Professor of Neurology and Chief of the Memory Disorders Division at the Barrow Neurological Institute.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: David Weisman, MD
Dr. David Weisman, neurologist with Abington Neurological Associates and Director of Abington Neurologic Association's Trial Center, talks about expert approaches to recognizing the signs and symptoms for Alzheimer's disease.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Douglas Scharre, MD, CMD
Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry with the Center for Cognitive and Memory Disorder at The Ohio State University Wexner Medical Center, speaks to the methods used for early detection of Alzheimer’s Disease, and their respective advantages vs costs in clinical practice.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
More than half of those seeking a diagnosis for dementia have delayed going to their doctor by at least a year, according to a survey carried out by the Alzheimer’s Society of Great Britain. Dr. Matt Birnholz reports.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Marwan Noel Sabbagh, MD, FAAN, CCRI
Dr. Marwan Sabbagh, Professor of Neurology and Chief of the Memory Disorders Division at Barrow Neurological Institute, describes some of his key priorities for the current and future state of Alzheimer’s care.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Douglas Scharre, MD, CMD
Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry and Director of the Center for Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center, explains the importance of early detection for Alzheimer's disease on patient quality of life, as well as broader impacts on American healthcare systems.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: Matt Birnholz, MD
Guest: Douglas Scharre, MD, CMD
Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry and Director of the Center for Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center, describes updated perspectives and understandings on the pathophysiology for Alzheimer's disease.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**
Host: John J. Russell, MD
Guest: Howard Fillit, MD
Quality care for patients with Alzheimer's disease starts with early recognition, which enables a timely diagnosis and subsequent intervention with the best available treatment and support options. As such, understanding the broad spectrum of signs and symptoms at the earliest stages of disease is absolutely critical.
Joining host Dr. John Russell to discuss the keys to early recognition for Alzheimer's Disease is Dr. Howard Fillit, founding Executive Director and Chief Science Officer for the Alzheimer's Drug Discovery Foundation.
Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection**